Goldman Sachs’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,195
Closed -$58K 5622
2021
Q3
$58K Sell
4,195
-8,001
-66% -$111K ﹤0.01% 5157
2021
Q2
$227K Sell
12,196
-107,291
-90% -$2M ﹤0.01% 4861
2021
Q1
$2.79M Sell
119,487
-4,405
-4% -$103K ﹤0.01% 3098
2020
Q4
$2.32M Sell
123,892
-22,822
-16% -$427K ﹤0.01% 2983
2020
Q3
$3.73M Buy
146,714
+52,540
+56% +$1.34M ﹤0.01% 2566
2020
Q2
$2.72M Buy
94,174
+81,446
+640% +$2.35M ﹤0.01% 2680
2020
Q1
$613K Buy
12,728
+2,225
+21% +$107K ﹤0.01% 3389
2019
Q4
$597K Sell
10,503
-253
-2% -$14.4K ﹤0.01% 3565
2019
Q3
$666K Buy
10,756
+1,373
+15% +$85K ﹤0.01% 3460
2019
Q2
$423K Sell
9,383
-3,493
-27% -$157K ﹤0.01% 3589
2019
Q1
$809K Sell
12,876
-1,526
-11% -$95.9K ﹤0.01% 3360
2018
Q4
$777K Buy
14,402
+1,485
+11% +$80.1K ﹤0.01% 3243
2018
Q3
$1.3M Buy
12,917
+7,066
+121% +$709K ﹤0.01% 3076
2018
Q2
$386K Buy
5,851
+2,691
+85% +$178K ﹤0.01% 3628
2018
Q1
$158K Sell
3,160
-1,944
-38% -$97.2K ﹤0.01% 3925
2017
Q4
$247K Buy
5,104
+1,649
+48% +$79.8K ﹤0.01% 3735
2017
Q3
$210K Sell
3,455
-932
-21% -$56.6K ﹤0.01% 3864
2017
Q2
$311K Sell
4,387
-351
-7% -$24.9K ﹤0.01% 3777
2017
Q1
$307K Sell
4,738
-1,404
-23% -$91K ﹤0.01% 3767
2016
Q4
$577K Buy
6,142
+4,856
+378% +$456K ﹤0.01% 3369
2016
Q3
$145K Buy
+1,286
New +$145K ﹤0.01% 4058
2016
Q2
Sell
-5,598
Closed -$275K 4593
2016
Q1
$275K Buy
5,598
+1,547
+38% +$76K ﹤0.01% 3599
2015
Q4
$197K Sell
4,051
-2,039
-33% -$99.2K ﹤0.01% 3749
2015
Q3
$256K Buy
6,090
+287
+5% +$12.1K ﹤0.01% 3693
2015
Q2
$269K Buy
5,803
+2,090
+56% +$96.9K ﹤0.01% 3800
2015
Q1
$149K Sell
3,713
-16
-0.4% -$642 ﹤0.01% 4020
2014
Q4
$180K Sell
3,729
-2,055
-36% -$99.2K ﹤0.01% 4032
2014
Q3
$280K Buy
+5,784
New +$280K ﹤0.01% 3703